e-sessions: free online learning for nurses

The European School of Oncology (ESO) has pioneered the concept of live online sessions for cancer professionals. These e-sessions include debates, conference highlights, teaching sessions and more.

The teaching sessions are known as grandrounds. These are:

  • a chance to hear live from an expert in your field
  • a chance to ask questions live
  • often CME accredited.

Some e-sessions are hosted in collaboration with EONS, and these tend to be of great relevance to your nursing practice.

+  View all EONS e-sessions

To access ESO’s e-sessions, you will first need to register with the e-ESO website and check your computer and browser meets the minimum system requirements. You can submit questions in advance of the session, ask them directly during the session or (in some cases) contact the expert afterwards.

If you miss an e-session, you can catch up later by watching a recording. Recordings of all e-sessions are available for 12 months after broadcast. The e-ESO site has an extensive archive of recorded sessions from the past year, all available for free.

+  View all recorded e-sessions

Future sessions

e-session 520002 - COVID-19 and radiation oncology: any clinical and organisational impact?
31 Mar 2020 - 18:15-19:00 CET
Expert: Berardino De Bari, Réseau Hospitalier Neuchâtelois, La Chaux-de-Fonds, Switzerland
Expert: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
Expert: Lofti Kochbati, Hôpital A Mami Ariana, Tunis, Tunisia
+  Go to this session

e-session 521 - Beyond PARP inhibition: pathways of potential clinical relevance and targeted treatments in ovarian cancer
02 Apr 2020 - 18:15-19:00 CET
Expert: Ilaria Colombo, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Discussant: Anastasios Stathis, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 521002 - Metastatic castrate-resistant prostate cancer (20MCO)
03 Apr 2020 - 15:30-16:15 CET
Expert: Karim Fizazi, Institut Gustave Roussy, University of Paris, Villejuif, France
+  Go to this session

e-session 521000 - Advanced breast cancer (20MCO)
06 Apr 2020 - 18:15-19:00 CET
Expert: Alexandru Eniu, Interdisciplinary Cancer Service, HRC Hopital Riviera-Chablais, Rennaz, Switzerland
Discussant: Olivia Pagani, Riviera-Chablais Hospital, Rennaz, Switzerland
+  Go to this session

e-session 521001 - COVID 19 – Oncological risks and guidelines
08 Apr 2020 - 18:15-19:00 CET
Expert: Stefano Cafarotti, Bellinzona and Valli Regional Hospital, Bellinzona, Switzerland
Expert: Angelo Delmonte, Romagna Scientific Institute for the Study and Cure of Cancer, Meldola, Italy
+  Go to this session

e-session 522 - The rare cancer oncology
09 Apr 2020 - 18:15-19:00 CET
Expert: Paolo Casali, National Cancer Institute - IRCCS Foundation, Milan, Italy
Discussant: Jean-Yves Blay, Université Claude Bernard Lyon & Centre Léon Bérard, Lyon, France
+  Go to this session

e-session 522001 - Lung cancer: clinical cases discussion (20MCO)
14 Apr 2020 - 18:15-19:00 CET
Expert: Dragana Jovanovic, Pulmonology University Hospital,Clinical Center of Serbia, Belgrade, Serbia
Expert: Tanja Cufer, University Clinic Golnik, Golnik, Slovenia
Expert: Rolf A. Stahel, University Hospital, Zurich, Switzerland
Expert: Erica Koch, Red de Salud UC-Christus / Pontificia Universidad Católica de Chile, Santiago, Chile
Expert: Ana Maria Popa, Elias University Hospital, Bucharest, Romania
Expert: Damiano Alfio Patané, Niguarda Hospital, Milan, Italy
+  Go to this session

e-session 522000 - Controversies in the treatment of follicular lymphoma
15 Apr 2020 - 18:15-19:00 CET
Expert: John P. Leonard, Weill Cornell Medicine, New York, USA
Discussant: Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina
+  Go to this session

e-session 523 - Uterine sarcomas
16 Apr 2020 - 18:15-19:00 CET
Expert: Paolo Casali, National Cancer Institute - IRCCS Foundation, Milan, Italy
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 523000 - FLASH radiotherapy: evolution or revolution?
22 Apr 2020 - 18:15-19:00 CET
Expert: Jean Bourhis, CHUV, Lausanne, Switzerland
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 524 - The role of molecular biomarkers and treatment landscape for advanced colorectal cancer
23 Apr 2020 - 18:15-19:00 CET
Expert: Nora Forones, UNIFESP - Federal University of Sao Paulo, Sao Paulo, Brazil
Discussant: Ramon De Mello, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
+  Go to this session

e-session 524000 - New ESMO guidelines for early breast cancer treatment
27 Apr 2020 - 18:15-19:00 CET
Expert: Elzbieta Senkus, Medical University of Gdansk, Gdansk, Poland
Discussant: Fatima Cardoso, Champalimaud Clinical Center, Lisbon, Portugal
+  Go to this session

e-session 524001 - Gastric cancer (20MCO)
28 Apr 2020 - 18:15-19:00 CET
Expert: Florian Lordick, University Hospital Leipzig, Leipzig, Germany
Discussant: Ramon De Mello, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
+  Go to this session

e-session 525 - Geriatric oncology services: what needs to be considered?
30 Apr 2020 - 18:15-19:00 CET
Expert: Michelle Hannan, University Hospital Waterford, Waterford, Ireland
Discussant: Patricia Fox, UCD School of Nursing, Midwifery and Health Systems, Dublin, Ireland
+  Go to this session

e-session 525001 - SCLC (20MCO)
04 May 2020 - 18:15-19:00 CET
Expert: Dragana Jovanovic, Pulmonology University Hospital,Clinical Center of Serbia, Belgrade, Serbia
Discussant: Angelo Delmonte, Romagna Scientific Institute for the Study and Cure of Cancer, Meldola, Italy
+  Go to this session

e-session 525000 - DLBCL: how to select which patients should be treated differently?
05 May 2020 - 18:15-19:00 CET
Expert: Sonali M. Smith, The University of Chicago, Chicago, USA
Discussant: Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina
+  Go to this session

e-session 526 - Bowel obstructions
07 May 2020 - 18:15-19:00 CET
Expert: Carla Ripamonti, IRCCS Foundation, National Cancer Institute, Milan, Italy
Discussant: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 526000 - Gynaecological cancers - clinical cases discussion (20MCO)
11 May 2020 - 18:15-19:00 CET
Expert: Michael Halaska, Charles University, Prague, Czech Republic
Expert: Gonzalo Giornelli, Instituto Alexander Fleming, Buenos Aires, Argentina
Expert: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Expert: Gabriela Krüger da Costa, Santa Casa de misericórdia de Porto Alegre, Porto Alegre, Brazil
+  Go to this session

e-session 526001 - Clinical case discussion: breast cancer in young women
12 May 2020 - 18:15-19:00 CET
Expert: Iuliana Pantelimon, Spitalul Clinic Cantacuzino, Bucharest, Romania
Expert: Olivia Pagani, Riviera-Chablais Hospital, Rennaz, Switzerland
Expert: Abeid Athman, Alexandria University Hospital, Alexandria, Egypt
Expert: Elene Mariamidze, Research Institute of Clinical Medicine, Tbilisi, Georgia
+  Go to this session

e-session 527 - New classification of gynaecological cancers
14 May 2020 - 18:15-19:00 CET
Expert: Frederique Penault-Llorca, Centre Jean Perrin, Clermont-Ferrand, France
Discussant: Ilaria Colombo, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 527002 - GI cancers - clinical cases discussion (20MCO)
15 May 2020 - 18:15-19:00 CET
Expert: Demetris Papamichael, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
Expert: Andrés Cervantes, Hospital Clinico Universitario, Valencia, Spain
+  Go to this session

e-session 527001 - Renal cancer (20MCO)
19 May 2020 - 18:15-19:00 CET
Expert: Maria De Santis, Charité University Hospital, Berlin, Germany
+  Go to this session

e-session 527000 - Doubts and evidence in the treatment of RR HL
20 May 2020 - 18:15-19:00 CET
Expert: Anna Sureda, Institut Català d'Oncologia, Hospital Duran i Reynals, Barcelona, Spain
Discussant: Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina
+  Go to this session

e-session 528 - Highlights of ESTRO 39
21 May 2020 - 18:15-19:00 CET
Expert: Andrea Riccardo Filippi, Policlinico S. Matteo IRCCS Foundation, Pavia, Italy
Expert: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 528000 - GU cancers: clinical cases discussion (20MCO)
26 May 2020 - 18:15-19:00 CET
Expert: Karim Fizazi, Institut Gustave Roussy, University of Paris, Villejuif, France
Expert: Elise Nassif, HEGP, Paris, France
Expert: Maria De Santis, Charité University Hospital, Berlin, Germany
Expert: Matias Chacon, Instituto Alexander Fleming, Buenos Aires, Argentina
+  Go to this session

e-session 529 - Hemophagocytic lymphohistiocytosis (HLH) (held in collaboration with SIOPe)
28 May 2020 - 18:15-19:00 CET
Expert: Caroline Hutter, St. Anna's Kinderspital, Vienna, Austria
Discussant: Andishe Attarbaschi, St. Anna's Chidren's Hospital, Vienna, Austria
+  Go to this session

e-session 529000 - Ovarian cancer (20MCO)
29 May 2020 - 18:15-19:00 CET
Expert: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 530 - Histiocytic disorders in childhood (held in collaboration with SIOPe)
04 Jun 2020 - 18:15-19:00 CET
Expert: Milen Minkov, Wiener Krankenanstalten Verbund, Vienna, Austria
+  Go to this session

e-session 530000 - Personalized treatment in MDS
05 Jun 2020 - 18:15-19:00 CET
Expert: Guillermo Garcia-Manero, MD Anderson Cancer Centre, Houston, TX, USA
Discussant: Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina
+  Go to this session

e-session 531 - Renal tumours of childhood (held in collaboration with SIOPe)
11 Jun 2020 - 18:15-19:00 CET
Expert: Norbert Graf, UKS – Universitätsklinikum des Saarlandes, Homburg, Germany
Discussant: Waltraud Friesenbichler, St. Anna's Kinderspital, Vienna, Austria
+  Go to this session

e-session 532 - Hodgkin's disease in childhood and adolescence (held in collaboration with SIOPe)
18 Jun 2020 - 18:15-19:00 CET
Expert: Auke Beishuizen, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
Discussant: Andishe Attarbaschi, St. Anna's Chidren's Hospital, Vienna, Austria
+  Go to this session

e-session 533 - Molecular testing in metastatic breast cancer care: where we are in 2020?
25 Jun 2020 - 18:15-19:00 CET
Expert: Barbara Pistilli, Institut Gustave Roussy, Villejuif, France
Discussant: Ines Vaz Luis, Gustave Roussy Institute, Villejuif, France
+  Go to this session

e-session 533000 - Aging and cancer symposium: highlights (held in collaboration with the Pezcoller Foundation)
30 Jun 2020 - 18:15-19:00 CET
+  Go to this session

e-session 534 - Update from the ESTS 2020 Congress
02 Jul 2020 - 18:15-19:00 CET
Expert: Pierre-Emmanuel Falcoz, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 535 - Management of CNS Tumours – with focus on anatomy of tumours and organs at risk for radiotherapy planning
09 Jul 2020 - 18:15-19:00 CET
Expert: Sarah Jefferies, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
Discussant: Gerben Borst, Antoni van Leeuwenhoec Cancer Institute, Amsterdam, The Netherlands
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 536 - Burn-out in oncology professionals
16 Jul 2020 - 18:15-19:00 CET
Expert: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
Discussant: Lorys Castelli, Turin University, Turin, Italy
+  Go to this session

e-session 537 - The role of MRgRT in pelvic malignancies
23 Jul 2020 - 18:15-19:00 CET
Expert: Vincenzo Valentini, Gemelli University Polyclinic, Rome, Italy
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 538 - Dose-escalation in lung cancer radiotherapy
30 Jul 2020 - 18:15-19:00 CET
Expert: Esther Troost, Carl Gustav Carus University Hospital, Dresden, Germany
Discussant: Andrea Riccardo Filippi, Policlinico S. Matteo IRCCS Foundation, Pavia, Italy
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 539 - ESGO/SIOPe guidelines in adolescents and AYA with non epithelial ovarian cancer
03 Sep 2020 - 18:15-19:00 CET
Expert: Gabriele Calaminus, Bonn University Hospital, Bonn, Germany
Expert: Philippe Morice, Gustave Roussy Institute, Villejuif, France
Discussant: Fedro A. Peccatori, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 540 - Acute lymphoblastic leukaemia in childhood and adolescence (held in collaboration with SIOPe)
10 Sep 2020 - 18:15-19:00 CET
Expert: Carmelo Rizzari, MBBM Foundation, ASST Monza, Monza, Italy
Discussant: Andishe Attarbaschi, St. Anna's Chidren's Hospital, Vienna, Austria
+  Go to this session

e-session 541 - Do we still need to excise primary focus of breast cancer in patients cCR following neoadjuvant therapy?
17 Sep 2020 - 18:15-19:00 CET
Expert: Marie Jeanne Vrancken Peeters, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Discussant: Wojciech Wysocki, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland
+  Go to this session

e-session 542 - Enhancer recovery after lung cancer treatments
24 Sep 2020 - 18:15-19:00 CET
Expert: Tim Batchelor, University Hospitals Bristol, Bristol, United Kingdom
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 543 - Prostate cancer app
01 Oct 2020 - 18:15-19:00 CET
Expert: Erik van Muilekom, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
Discussant: Lawrence Drudge Coates, King's College Hospital NHS Foundation Trust, London, United Kingdom
+  Go to this session

e-session 544 - Molecular research on malignant pleural mesothelioma
08 Oct 2020 - 18:15-19:00 CET
Expert: Riccarda Granata, University of Turin, Turin, Italy
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 545 - Update from the WCLC 2020 Congress
15 Oct 2020 - 18:15-19:00 CET
Expert: Pietro Bertoglio, IRCCS Sacro Cuore-Don Calabria Hospital and Cancer Care Centre, Verona, Italy
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 546 - 2020 literature update of lung cancer surgery
22 Oct 2020 - 18:15-19:00 CET
Expert: Calvin Sze Hang NG, The Chinese University of Hong Kong, Hong Kong SAR, China
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 564000 - Choosing between research and clinic  
26 Oct 2020 - 18:15-19:00 CET
Expert: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Discussant: Ines Vaz Luis, Gustave Roussy Institute, Villejuif, France
+  Go to this session

e-session 547 - Automation in radiation oncology
29 Oct 2020 - 18:15-19:00 CET
Expert: Steven Petit, Daniel Den Hoed Cancer Center, Erasmus MC, Rotterdam, The Netherlands
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 548 - PARP inhibitors in ovarian cancer - an update
05 Nov 2020 - 18:15-19:00 CET
Expert: Mansoor Raza Mirza, Rigshospitalet, Copenhagen, Denmark
Discussant: Mikkel Rosendahl, Rigshospitalet, Copenhagen, Denmark
+  Go to this session

e-session 549 - The Toronto Childhood Cancer Stage Guidelines – an overview
12 Nov 2020 - 18:15-19:00 CET
Expert: Lindsay Frazier, Dana-Farber Cancer Institute, Boston, MA, USA
Expert: Sumit Gupta, The Hospital for Sick Children, Toronto, Canada
Expert: Joanne Aitken, Cancer Council Queensland, Fortitude Valley, QLD, Australia
+  Go to this session

e-session 550 - The Toronto Childhood Cancer Stage Guidelines – practical application
19 Nov 2020 - 18:15-19:00 CET
Expert: Lindsay Frazier, Dana-Farber Cancer Institute, Boston, MA, USA
Expert: Sumit Gupta, The Hospital for Sick Children, Toronto, Canada
Expert: Joanne Aitken, Cancer Council Queensland, Fortitude Valley, QLD, Australia
+  Go to this session

e-session 550000 - Preoperative radiotherapy in early breast cancer
23 Nov 2020 - 18:15-19:00 CET
Expert: Philip Poortmans, Paris Sciences et Lettres University, Paris, France
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 551 - Oncological management of malignant pleural mesothelioma
26 Nov 2020 - 18:15-19:00 CET
Expert: Federica Grosso, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e C. Arrigo, Alessandria, Italy
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 551000 - A critical appraisal on lung cancer guidelines
02 Dec 2020 - 18:15-19:00 CET
Expert: Francesco Passiglia, University of Turin, San Luigi Hospital, Orbassano, Italy
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 552 - Osteosarcoma (held in collaboration with SIOPe)
03 Dec 2020 - 18:15-19:00 CET
Expert: Stefan Bielack, Olgahospital, Stuttgart, Germany
Discussant: Leo Kager, St. Anna's Children's Hospital, Vienna, Austria
+  Go to this session

e-session 553 - Future trends of molecular testing and BRAF inhibitors for advanced colorectal cancer treatment
10 Dec 2020 - 18:15-19:00 CET
Expert: Antonia Digklia, CHUV, Lausanne, Switzerland
Discussant: Ramon De Mello, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
+  Go to this session

e-session 554 - Guidelines in endometrial cancer
17 Dec 2020 - 18:15-19:00 CET
Expert: Nicoletta Colombo, European Institute of Oncology, Milan, Italy
Discussant: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 523001 - Writing an article and getting published        
20 Apr 2021 - 18:15-19:00 CET
Expert: Ian Tannock, Princess Margaret Hospital, Toronto, Canada
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

Past sessions

e-session 520001 - Breast cancer - clinical cases discussion (20MCO)
27 Mar 2020 - 18:15-19:00 CET
Expert: Alexandru Eniu, Interdisciplinary Cancer Service, HRC Hopital Riviera-Chablais, Rennaz, Switzerland
Expert: Petra Vukovic, University Hospital for Tumors, Zagreb, Croatia
Expert: Félix Gremonprez, Ghent University Hospital, Gent, Belgium
Expert: Olivia Pagani, Riviera-Chablais Hospital, Rennaz, Switzerland
Expert: Ma. De los Ángeles López Vega, Hospital General de Zona No. 15 del Instituto Mexicano del Seguro Social, Reynosa, Tamaulipas, Mexico
Expert: Elzbieta Senkus, Medical University of Gdansk, Gdansk, Poland
+  Go to this session

e-session 520000 - Colon cancer adjuvant therapy in 2020 (20MCO)
27 Mar 2020 - 12:30-13:15 CET
Expert: Demetris Papamichael, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
Discussant: Ramon De Mello, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
+  Go to this session

e-session 520004 - OncoAlert Round Table Discussions: The Global COVID19 Experience
26 Mar 2020 - 18:15-19:00 CET
Expert: Marina Garassino, National Cancer Institute, Milan, Italy
Expert: Solange Peters, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Discussant: Gilberto Morgan, Skåne University Hospital, Lund, Sweden
+  Go to this session

e-session 520 - Use of technology for monitoring symptoms in patients receiving cancer treatment
26 Mar 2020 - 18:15-19:00 CET
Expert: Roma Maguire, University of Strathclyde, Glasgow, United Kingdom
Discussant: Virpi Sulosaari, Turku University of Applied Sciences, Turku, Finland
+  Go to this session

e-session 519000 - The role of immune-checkpoints inhibitors for advanced colorectal cancer treatment
25 Mar 2020 - 18:15-19:00 CET
Expert: Ramon De Mello, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
Discussant: Antonia Digklia, CHUV, Lausanne, Switzerland
+  Go to this session

e-session 519001 - Early breast cancer (20MCO)
23 Mar 2020 - 14:30-15:15 CET
Expert: Olivia Pagani, Riviera-Chablais Hospital, Rennaz, Switzerland
Discussant: Wojciech Wysocki, Andrzej Frycz Modrzewski Krakow University, Krakow, Poland
+  Go to this session

e-session 519 - Patient-reported outcomes: ready for clinical practice?
19 Mar 2020 - 18:15-19:00 CET
Expert: Ines Vaz Luis, Gustave Roussy Institute, Villejuif, France
Discussant: Antonio Di Meglio, Gustave Roussy Institute, Villejuif, France
+  Go to this session

e-session 518000 - The impact of coronavirus on oncological care
18 Mar 2020 - 18:15-19:00 CET
Expert: Alexandru Eniu, Interdisciplinary Cancer Service, HRC Hopital Riviera-Chablais, Rennaz, Switzerland
Expert: Stefano Cafarotti, Bellinzona and Valli Regional Hospital, Bellinzona, Switzerland
Expert: Marco Siano, Interdisciplinary Cancer Service, HRC Hopital Riviera-Chablais, Rennaz, Switzerland
+  Go to this session

e-session 518002 - OncoAlert Round Table The Italian COVID19 Experience
17 Mar 2020 - 18:15-19:00 CET
+  Go to this session

e-session 518 - The impact of culture and ethnicity on genetic counselling
12 Mar 2020 - 18:15-19:00 CET
Expert: Shenela Lakhani, Weill Cornell Medical College, New York, USA
Discussant: Jonas Feilchenfeldt, Hôpital Riviera Chablais, Vevey, Switzerland
+  Go to this session

e-session 517 - Nurse education in the United Kingdom
05 Mar 2020 - 18:15-19:00 CET
Expert: Susanne Cruickshank, University of Stirling, Stirling, United Kingdom
Discussant: Wendy McInally, Edinburgh Napier University, Edinburgh, United Kingdom
+  Go to this session

e-session 516 - Liquid biopsy in lung cancer
27 Feb 2020 - 18:15-19:00 CET
Expert: Christian Rolfo, University of Maryland, Baltimore, USA
Discussant: Umberto Malapelle, University of Naples Federico II, Naples, Italy
Discussant: Sanjay Popat, The Royal Marsden NHS Foundation Trust, London, United Kingdom
+  Go to this session

e-session 515000 - Has immunotherapy kept its promises in malignant lymphoma? (20MCO)
26 Feb 2020 - 18:15-19:00 CET
Expert: Franco Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 515 - Gynaecological cancers and pregnancy
20 Feb 2020 - 18:15-19:00 CET
Expert: Michael Halaska, Charles University, Prague, Czech Republic
Discussant: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 514000 - Hyperprogressive disease in patients with NSCLC
17 Feb 2020 - 18:00-19:00 CET
Expert: Roberto Ferrara, Istituto Nazionale dei Tumori, Milan, Italy
+  Go to this session

e-session 514 - Holistic needs assessment
13 Feb 2020 - 18:15-19:00 CET
Expert: Karen Campbell, Edinburgh Napier University, Edinburgh, United Kingdom
Discussant: Sandra Campbell, Macmillan Nurse Consultant for Cancer & Palliative Care, Falkirk, United Kingdom
+  Go to this session

e-session 513 - Highlights of SABCS 2019
06 Feb 2020 - 18:15-19:00 CET
Expert: Joana Ribeiro, Champalimaud Clinical Center, Lisbon, Portugal
Discussant: Antonio Di Meglio, Gustave Roussy Institute, Villejuif, France
+  Go to this session

e-session 512 - Highlights of the Advanced Prostate Cancer Consensus Conference (APCCC) 2019
30 Jan 2020 - 18:15-19:00 CET
Expert: Aurelius Omlin, Kantonsspital St. Gallen, St Gallen, Switzerland
Discussant: Carmel Pezaro, Sheffield Teaching Hospital, Sheffield, United Kingdom
+  Go to this session

e-session 511000 - How Social Media Can Impact Oncology and How To Get Started
28 Jan 2020 - 18:15-19:00 CET
Expert: Gilberto Morgan, Skåne University Hospital, Lund, Sweden
+  Go to this session

e-session 511 - Highlights of ABC5 - ESO-ESMO Advanced Breast Cancer Fifth International Consensus Conference
23 Jan 2020 - 18:15-19:00 CET
Expert: Fatima Cardoso, Champalimaud Clinical Center, Lisbon, Portugal
Discussant: Giuseppe Curigliano, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 510000 - Lung Cancer Surgery: an Editor's perspective
17 Jan 2020 - 17:30-18:15 CET
Expert: Alan D.L. Sihoe, The University of Hong Kong, Hong Kong, Hong Kong
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 510 - Benign stricture of the esophagus and hypopharynx
16 Jan 2020 - 18:15-19:00 CET
Expert: Massimo Conio, Sanremo Hospital, Sanremo, Italy
Discussant: Michael Häfner, Private practice, Vienna, Austria
+  Go to this session

e-session 509001 - Management of elderly women (CCB 2019)
01 Jan 2020 - 18:15-19:00 CET
Expert: Matti Aapro, Genolier Cancer Centre, Genolier, Switzerland
+  Go to this session

e-session 509 - Things about breast cancer that keep us up at night - Part II
19 Dec 2019 - 18:15-19:00 CET
Expert: Hope S. Rugo, University of California San Francisco, San Francisco, USA
Discussant: Olivia Pagani, Riviera-Chablais Hospital, Rennaz, Switzerland
+  Go to this session

e-session 509000 - Challenges for Clinical Practice with Immune Checkpoint Inhibitors in #lungCancer
19 Dec 2019 - 18:15-19:00 CET
Expert: Gilberto Morgan, Skåne University Hospital, Lund, Sweden
Expert: Luis Castelo-Branco, Clinical Oncology Algarve Medical and University Centre Faro, Faro, Portugal
+  Go to this session

e-session 508 - PARP inhibitors in primary and recurrent ovarian cancer
12 Dec 2019 - 18:15-19:00 CET
Expert: Mansoor Raza Mirza, Rigshospitalet, Copenhagen, Denmark
Discussant: Mikkel Rosendahl, Rigshospitalet, Copenhagen, Denmark
+  Go to this session

e-session 507 - The role of nodal irradiation in breast cancer
05 Dec 2019 - 18:15-19:00 CET
Expert: Lise Thorsen, Aarhus University Hospital, Aarhus C, Denmark
Expert: Birgitte V. Offersen, Aarhus University Hospital, Aarhus C, Denmark
Discussant: Icro Meattini, Florence University, Florence, Italy
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 506000 - NHL in childhood and adolescence (held in collaboration with SIOPe)
04 Dec 2019 - 18:15-19:00 CET
Expert: Andishe Attarbaschi, St. Anna's Chidren's Hospital, Vienna, Austria
Discussant: Fiona Poyer, St. Anna's Kinderspital, Vienna, Austria
+  Go to this session

e-session 506001 - Predictive molecular pathology in non-small cell lung cancer
02 Dec 2019 - 17:00-18:00 CET
Expert: Umberto Malapelle, University of Naples Federico II, Naples, Italy
+  Go to this session

e-session 506031 - Quality of evidence in rare cancers (19RAR)
01 Dec 2019 - 18:15-19:00 CET
Expert: Paolo Bruzzi, Institute for Cancer Research, Genoa, Italy
+  Go to this session

e-session 506032 - Biliary tumours (19RAR)
01 Dec 2019 - 18:15-19:00 CET
Expert: Monica Niger, National Cancer Institute, Milan, Italy
+  Go to this session

e-session 506033 - Anal carcinoma (19RAR)
01 Dec 2019 - 18:15-19:00 CET
Expert: Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex, United Kingdom
+  Go to this session

e-session 506034 - Peritoneal mesothelioma and pseudomyxoma peritonei (19RAR)
01 Dec 2019 - 18:15-19:00 CET
Expert: Marcello Deraco, IRCCS Foundation, National Institute of Cancer, Milan, Italy
+  Go to this session

e-session 506035 - Thoracic neuroendocrine tumours (19RAR)
01 Dec 2019 - 18:15-19:00 CET
Expert: Eric Baudin, Institut Gustave-Roussy, Villejuif, France
+  Go to this session

e-session 506036 - Gastroenteropancreatic neuroendocrine tumours (19RAR)
01 Dec 2019 - 18:15-19:00 CET
Expert: Nicola Fazio, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 506037 - Surgery in neuroendocrine tumours (19RAR)
01 Dec 2019 - 18:15-19:00 CET
Expert: Michele Droz Dit Busset, IRCCS Foundation - National Cancer Institute, Milan, Italy
+  Go to this session

e-session 506014 - The scope of pathologic diagnosis in rare cancers: which molecular profiling should be provided today? (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Angelo Paolo Dei Tos, University of Padua School of Medicine, Padua, Italy
+  Go to this session

e-session 506015 - Merkel cell carcinoma (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Celeste Lebbè, Saint Louis Hospital, Paris, France
+  Go to this session

e-session 506016 - Cutaneous adnexal malignancies (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Stefano Cavalieri, IRCCS Foundation - National Cancer Institute, Milan, Italy
+  Go to this session

e-session 506017 - Uveal melanoma (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Martina Angi, National Cancer Institute - IRCCS Foundation, Milan, Italy, Milan, Italy
+  Go to this session

e-session 506018 - Laryngeal and hypopharyngeal carcinoma (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Lisa Licitra, National Cancer Institute - IRCCS Foundation, Milan, Italy
+  Go to this session

e-session 506019 - Oropharyngeal carcinoma (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Jesper Grau Eriksen, Odense University Hospital, Odense, Denmark
+  Go to this session

e-session 506020 - Nasopharyngeal carcinoma and sinonasal cancers (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Lisa Licitra, National Cancer Institute - IRCCS Foundation, Milan, Italy
+  Go to this session

e-session 506021 - Salivary gland tumours (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Laura Locati, National Cancer Institute - IRCCS Foundation, Milan, Italy
+  Go to this session

e-session 506022 - Oral cavity tumours (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Cesare Piazza, National Cancer Institute - IRCCS Foundation, Milan, Italy
+  Go to this session

e-session 506023 - Adult soft tissue sarcomas (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Paolo Casali, National Cancer Institute - IRCCS Foundation, Milan, Italy
+  Go to this session

e-session 506024 - GIST (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Jean-Yves Blay, Université Claude Bernard Lyon & Centre Léon Bérard, Lyon, France
+  Go to this session

e-session 506025 - Preoperative chemo-radiation therapy in STS (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Alessandro Gronchi, National Cancer Institute - IRCCS Foundation, Milan, Italy
+  Go to this session

e-session 506026 - Rare bone sarcomas (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Silvia Stacchiotti, National Cancer Institute - IRCCS Foundation, Milan, Italy
+  Go to this session

e-session 506027 - Ewing sarcoma and osteosarcoma (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Stefan Bielack, Olgahospital, Stuttgart, Germany
+  Go to this session

e-session 506028 - Being histologically agnostic in rare cancers (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Jean-Yves Blay, Université Claude Bernard Lyon & Centre Léon Bérard, Lyon, France
+  Go to this session

e-session 506029 - Adreanal cancer (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Salvatore Grisanti, A.O. Spedali Civili, Brescia, Italy
+  Go to this session

e-session 506030 - Thyroid cancer (19RAR)
30 Nov 2019 - 18:15-19:00 CET
Expert: Kate Newbold, The Royal Marsden, London, UK
+  Go to this session

e-session 506002 - The problem of rare cancer (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Paolo Casali, National Cancer Institute - IRCCS Foundation, Milan, Italy
+  Go to this session

e-session 506003 - Networking on rare cancers (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Anna Maria Frezza, National Cancer Institute - IRCCS Foundation, Milan, Italy
+  Go to this session

e-session 506004 - What can we do politically? (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Francesco De Lorenzo, European Cancer Patient Coalition, Brussels, Belgium
Expert: Kathy Oliver, International Brain Tumour Alliance - IBTA, Tadworth, Surrey, United Kingdom
+  Go to this session

e-session 506005 - Collaborative clinical registries in rare cancers (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Rolf A. Stahel, University Hospital, Zurich, Switzerland
+  Go to this session

e-session 506006 - Gliomas (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Riccardo Soffietti, AOU San Giovanni Battista, Turin, Milan
+  Go to this session

e-session 506007 - Rare CNS tumours (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Ahmed Idbaih, APHP Hopital Pitié de la Salpetriére, Paris, France
+  Go to this session

e-session 506008 - Molecular approaches to CNS tumours (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Riccardo Soffietti, AOU San Giovanni Battista, Turin, Milan
+  Go to this session

e-session 506009 - New developments in surgery of CNS tumours (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Hugues Duffau, Hopital Gui de Chauliac, Montpellier, France
+  Go to this session

e-session 506010 - Mesothelioma (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Rolf A. Stahel, University Hospital, Zurich, Switzerland
+  Go to this session

e-session 506011 - Thymic tumours (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Marina Garassino, National Cancer Institute, Milan, Italy
+  Go to this session

e-session 506012 - Non-epithelial ovarian tumours (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, France
+  Go to this session

e-session 506013 - Tromphoblastic tumours (19RAR)
29 Nov 2019 - 18:15-19:00 CET
Expert: Michael Seckl, Hammersmith Campus, London, United Kingdom
+  Go to this session

e-session 506 - Role of the cancer nurse in cancer prevention
28 Nov 2019 - 18:15-19:00 CET
Expert: Dimitrios Protogiros, National and Kapodistrian University of Athens, Athens, Greece
Discussant: Gilberto Morgan, Skåne University Hospital, Lund, Sweden
+  Go to this session

e-session 505001 - Pregnancy associated breast cancer (CCB 2019)
26 Nov 2019 - 18:15-19:00 CET
Expert: Sibylle Loibl, German Breast Group, GBG Forschungs GmbH, Neu-Isenburg, Germany
+  Go to this session

e-session 505 - Advances in stage III unresectable lung cancer: combining radio-chemotherapy with immuno-oncology
21 Nov 2019 - 18:15-19:00 CET
Expert: Andrea Riccardo Filippi, Policlinico S. Matteo IRCCS Foundation, Pavia, Italy
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
Discussant: Diego Luigi Cortinovis, San Gerardo Hospital, Monza, Italy
+  Go to this session

e-session 505000 - The current landscape of standard of care and new drug development in HER2+ metastatic breast cancer
18 Nov 2019 - 18:15-19:00 CET
Expert: Philippe Aftimos, Jules Bordet Institute, Brussels, Belgium
+  Go to this session

e-session 504000 - Immunotherapy in upper GI tumors
15 Nov 2019 - 18:15-19:00 CET
Expert: Sara De Dosso, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
Discussant: Florian Lordick, University Hospital Leipzig, Leipzig, Germany
+  Go to this session

e-session 504023 - Understanding and applying biology knowledge: Next generation sequencing for clinical decisions: friend or foe (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Fabrice André, Gustave Roussy Institute, Villejuif, France
+  Go to this session

e-session 504024 - Understanding and applying biology knowledge: Is lobular ABC a separate entity? (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Sabine Linn, NKI–AVL, Amsterdam, The Netherlands
+  Go to this session

e-session 504025 - Understanding and applying biology knowledge: De novo cv recurrent ABC (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Prudence A. Francis, Peter MacCallum Cancer Centre, Melbourne, Australia
+  Go to this session

e-session 504026 - Understanding and applying biology knowledge: Biomarkers for new approaches: what have been doing wrong? (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Aleix Prat, Hospital Clínic of Barcelona, Barcelona, Spain
+  Go to this session

e-session 504027 - FEMAMA’s strategies to ensure HER2+ breast cancer treatments in Brazil (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Maira Caleffi, Federação Brasileira de Instituições Filantrópicas de Apoio à Saúde da Mama, Porto Alegre, Brazil
+  Go to this session

e-session 504028 - T-DM1 efficacy and activity in HER2-positive metastatic breast cancer patients progressing after frontline taxane plus pertuzumab and trastuzumab (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Benedetta Conte, Ospedale Policlinico San Martino, Genova, Italy
+  Go to this session

e-session 504029 - A targeted survey of Belong.life Advanced Breast Cancer patients, focusing on patient’s reported outcomes, real world evidence and insights in reducing the burden of financial toxicity (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Daniel Vorobiof, Belong.life, New York, USA
+  Go to this session

e-session 504030 - Latest news: Triple negative ABC: Standards of care and optimal options (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Hope S. Rugo, University of California San Francisco, San Francisco, USA
+  Go to this session

e-session 504031 - Latest news: Triple negative ABC: New targets, new drugs (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Andrew Tutt, Breakthrough Breast Cancer Research Unit, King's College London School of Medicine, London, United Kingdom
+  Go to this session

e-session 504032 - Latest news: Triple negative ABC: Biology and resistance (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Giuseppe Curigliano, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 504033 - Managing side effects and difficult symptoms: Overcoming global hurdles in pain management: from morphine shortage to opiod abuse (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Matti Aapro, Genolier Cancer Centre, Genolier, Switzerland
+  Go to this session

e-session 504034 - Managing side effects and difficult symptoms: Gyneacological and sexual symptoms: the silent suffering (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Christoph Thomssen, Martin Luther University, Halle/Saale, Germany
+  Go to this session

e-session 504035 - Managing side effects and difficult symptoms: Fatigue and cachexia: from biology to solutions (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Carlos H. Barrios, PURCS School of Medicine, Porto Alegre, Brasil
+  Go to this session

e-session 504036 - Latest news: Luminal ABC: Standards of care and optimal options (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Joseph Gligorov, Hopital Tenon-Hopital de Jour, Paris, France
+  Go to this session

e-session 504037 - Latest news: Luminal ABC: New targets, new drugs (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Peter Schmid, Barts Cancer Institute, London, UK
+  Go to this session

e-session 504038 - Latest news: Luminal ABC: Biology and resistance (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Carsten Denkert, Philipps University Marburg, Marburg, Germany
+  Go to this session

e-session 504039 - Specific sites of metastases: Update on systemic therapy of brain metastases (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Nancy Lin, Dana-Farber Cancer Institute, Boston, USA
+  Go to this session

e-session 504040 - Specific sites of metastases: Leptomeningeal disease (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Laura Biganzoli, Hospital of Prato, Prato, Italy
+  Go to this session

e-session 504041 - Specific sites of metastases: The role of new RT techniques for metastases treatment (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Birgitte V. Offersen, Aarhus University Hospital, Aarhus C, Denmark
+  Go to this session

e-session 504042 - Latest news: HER2+ ABC: Standards of care and optimal options (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Lisa A. Carey, University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, US
+  Go to this session

e-session 504043 - Latest news: HER2+ ABC: New targets, new drugs (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Javier Cortes, Vall d'Hebron Institute of Oncology, Barcelona, Spain
+  Go to this session

e-session 504044 - Latest news: HER2+ ABC: Biology and resitance (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Frederique Penault-Llorca, Centre Jean Perrin, Clermont-Ferrand, France
+  Go to this session

e-session 504045 - Improving monitoring of efficancy and toxicity: Implement PROMs in clinical research and clinical practice (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Lesley Fallowfield, Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton, United Kingdom
+  Go to this session

e-session 504046 - Improving monitoring of efficancy and toxicity: Optimal imaging techniques for bone only disease (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Frederic Lecouvet, Universite Catholique de Louvain, Brussel, Belgium
+  Go to this session

e-session 504047 - Improving monitoring of efficancy and toxicity: The role of liquid biopsies (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Paul Mainwaring, Canossa Private Hospital, Brisbane, Australia
+  Go to this session

e-session 504048 - Patient Advocacy session: Improving your communication skills: Doctors need to believe in miracles too: ensuring your understan therapeutic aims of treatment reccomandations (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Lesley Fallowfield, Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton, United Kingdom
+  Go to this session

e-session 504049 - Patient Advocacy session: Improving your communication skills: Building communication skills in health professional - the role that advocated can play (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Peter Boyle, International Prevention Research Institute, Lyon, France
+  Go to this session

e-session 504050 - Patient Advocacy session: Improving your communication skills: The power of storytelling in advocating for change - 3 case studies (ABC5)
15 Nov 2019 - 18:15-19:00 CET
Expert: Shirley A. Mertz, Metastatic Breast Cancer Network, Inverness, Ilinois, USA
Expert: Kristen Pilatti, Breast Cancer Network Australia, Camberwell, Australia
+  Go to this session

e-session 504001 - Patient Advocacy session: Complementary medicine: what helps and what doesn’t (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Maria João Cardoso, Champalimaud Clinical Center, Lisbon, Portugal
+  Go to this session

e-session 504002 - Patient Advocacy session: New drugs, different side effect: can complimentary medicine help? (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Christoph Thomssen, Martin Luther University, Halle/Saale, Germany
+  Go to this session

e-session 504003 - Patient Advocacy session: The danger of being lost between two worlds (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Renate Haidinger, Breast Cancer Germany TV, Hohenbrunn, Germany
+  Go to this session

e-session 504004 - Patient Advocacy session: Accessing palliative care - why the resistance? (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Matti Aapro, Genolier Cancer Centre, Genolier, Switzerland
+  Go to this session

e-session 504005 - Patient Advocacy session: Navigating end of life conversations with family members and children (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Luzia Travado, Champalimaud Cancer Center, Lisbon, Portugal
+  Go to this session

e-session 504006 - Patient Advocacy session: Supporting decision making and advance care planning - a case study of two patients (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Eva Schumacher, Mamma Mia! Das Brustkrebsmagazin, Kronberg, Germany
Expert: Nathalie Baudais, Patient Advocate, Thode, Canada
+  Go to this session

e-session 504007 - Patient Advocacy session: Bereavement support in the MBC community (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Shawna Rich-Ginsberg, Rethink Breast Cancer/Women's College Hospital, Toronto, Canada
+  Go to this session

e-session 504008 - A good doctor treats the disease; a great doctor treats the patient with the disease. How not to lose the joy of living in the fear of dying (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Claire Myerson, Patient Advocate, Oxford, UK
+  Go to this session

e-session 504009 - Meaningful clinical benefit: Applying the ESMO-MCBS in ABC systemic therapies (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Shani Paluch-Shimon, Shaare Zedek Medical Centre, Jerusalem, Israel
+  Go to this session

e-session 504010 - Meaningful clinical benefit: Optimal endpoints for ABC clinical trials: Can we aim for more? (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Nadia Harbeck, Breast Centre, University of Munich, Munich, Germany
+  Go to this session

e-session 504011 - Meaningful clinical benefit: Optimizing Clinical Trial Designs in ABC - Reaching Relevant Clinical Benefit (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Eric Paul Winer, Dana-Farber Cancer Institute, Boston, USA
+  Go to this session

e-session 504012 - Meaningful clinical benefit: Estimating and communicating survival times for each ABC patient (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Belinda Kiely, Sydney Medical School, Sydney, Australia
+  Go to this session

e-session 504013 - Meaningful clinical benefit: The role of big data and real-world data (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: George W. Sledge, IU Simon Cancer Center, Indianapolis, IN, USA
+  Go to this session

e-session 504014 - Discussing the hardest issues: When to stop and who decides? (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Gabriella Pravettoni, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 504015 - Discussing the hardest issues: Suicide and assisted suicide in ABC patients (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Uwe Güth, Brustzentrum Zürich, Zurig, Switzerland
+  Go to this session

e-session 504016 - Discussing the hardest issues: Optimal end of life care (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Karen Gelmon, BC Cancer Foundation, Vancouver, BC, Canada
+  Go to this session

e-session 504017 - Patient Advocacy session: Skin metastasis: the extension of the problem (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Maria João Cardoso, Champalimaud Clinical Center, Lisbon, Portugal
+  Go to this session

e-session 504018 - Patient Advocacy session: Do skin metastases have different biology? (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Joana Ribeiro, Champalimaud Clinical Center, Lisbon, Portugal
+  Go to this session

e-session 504019 - Patient Advocacy session: Skin directed therapy: Electrochemotherapy, is it a real option? (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Giuseppe Curigliano, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 504020 - Patient Advocacy session: Skin directed therapy: Radiotherapy and topical therapy (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Birgitte V. Offersen, Aarhus University Hospital, Aarhus C, Denmark
+  Go to this session

e-session 504021 - Patient Advocacy session: Taking care of maligman wound - what should be considered? (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Christine Boers-Doets, Leiden University Medical Center, Leiden, The Netherlands
+  Go to this session

e-session 504022 - ABC5 Award and lecture: Making a difference for advanced breast cancer patients (ABC5)
14 Nov 2019 - 18:15-19:00 CET
Expert: Fatima Cardoso, Champalimaud Clinical Center, Lisbon, Portugal
+  Go to this session

e-session 504 - Cost/effectiveness analysis in lung cancer surgery
14 Nov 2019 - 18:15-19:00 CET
Expert: Alessandro Brunelli, University of Leeds, Leeds, United Kingdom
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 503 - Liquid biopsy in lymphoma
07 Nov 2019 - 18:15-19:00 CET
Expert: Davide Rossi, Oncology Institue of Southern Switzerland (IOSI), Bellinzona, Switzerland
Discussant: Mark Roschewski, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA
+  Go to this session

e-session 502 - Clinical pharmacology of targeted treatments
31 Oct 2019 - 18:15-19:00 CET
Expert: Markus Jörger, Cantonal Hospital, St.Gallen, Switzerland
Discussant: Alwin Huitema, Netherlands Cancer Institute, Amsterdam, The Netherlands
+  Go to this session

e-session 501001 - New treatment options in CLL
31 Oct 2019 - 15:15-16:00 CET
Expert: Michael Hallek, University of Cologne, Cologne, Germany
Discussant: Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina
+  Go to this session

e-session 501000 - Pharmacology of anticancer drugs (part II)
29 Oct 2019 - 15:00-15:45 CET
Expert: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Discussant: Markus Jörger, Cantonal Hospital, St.Gallen, Switzerland
+  Go to this session

e-session 501 - Surgery in mesothelioma
24 Oct 2019 - 18:15-19:00 CET
Expert: Apostolos Nakas, University Hospitals of Leicester, Leicester, United Kingdom
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 500012 - Gastric Cancer: First line therapy and beyond (Refresher on GI)
19 Oct 2019 - 18:15-19:00 CET
Expert: Tomislav Omrcen, University Hospital of Split, Medical School of Split, Split, Croatia
+  Go to this session

e-session 500013 - Gastric Cancer: Optimal peri-operative therapy for localised gastric/GEJ cancer (Refresher on GI)
19 Oct 2019 - 18:15-19:00 CET
Expert: Stefano Cascinu, University of Modena and Reggio Emilia, Modena, Italy
+  Go to this session

e-session 500014 - Molecular classification of gastric cancer – ready for prime time? (Refresher on GI)
19 Oct 2019 - 18:15-19:00 CET
Expert: Stefano Cascinu, University of Modena and Reggio Emilia, Modena, Italy
+  Go to this session

e-session 500003 - Optimal management of stage II and III colon cancer (Refresher on GI)
18 Oct 2019 - 18:15-19:00 CET
Expert: John Souglakos, University Hospital of Heraklion, Heraklion, Greece
+  Go to this session

e-session 500005 - Best approach for the management of oligometastatic disease (Refresher on GI)
18 Oct 2019 - 18:15-19:00 CET
Expert: Demetris Papamichael, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
+  Go to this session

e-session 500004 - Review of the ESMO consensus conference for mCRC (Refresher on GI)
18 Oct 2019 - 18:15-19:00 CET
Expert: John Souglakos, University Hospital of Heraklion, Heraklion, Greece
+  Go to this session

e-session 500006 - Liquid biopsy – potential uses in CRC (Refresher on GI)
18 Oct 2019 - 18:15-19:00 CET
Expert: Demetris Papamichael, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
+  Go to this session

e-session 500007 - Optimal management of ‘liver only’ mCRC (Refresher on GI)
18 Oct 2019 - 18:15-19:00 CET
Expert: Borislav Belev, Clinic of Oncology, Unviersity Hospital Zagreb, Zagreb, Croatia
+  Go to this session

e-session 500008 - Pre-operative management of rectal cancer - state of the art (Refresher on GI)
18 Oct 2019 - 18:15-19:00 CET
Expert: Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex, United Kingdom
+  Go to this session

e-session 500009 - The use of chemotherapy in rectal cancer - current controversies (Refresher on GI)
18 Oct 2019 - 18:15-19:00 CET
Expert: Robert Glynne-Jones, Mount Vernon Centre for Cancer Treatment, Northwood, Middlesex, United Kingdom
+  Go to this session

e-session 500010 - Optimal staging of rectal cancer and management implications (Refresher on GI)
18 Oct 2019 - 18:15-19:00 CET
Expert: Paris Tekkis, The Royal Marsden Hospital, London, UK
+  Go to this session

e-session 500011 - Surgical aspects and management pitfalls in non-metastatic rectal cancer (Refresher on GI)
18 Oct 2019 - 18:15-19:00 CET
Expert: Paris Tekkis, The Royal Marsden Hospital, London, UK
+  Go to this session

e-session 500002 - Histopathological and Molecular staging of colon cancer (Refresher on GI)
18 Oct 2019 - 18:15-19:00 CET
Expert: Frederic Bibeau, CHU de Caen, Caen, France
+  Go to this session

e-session 500001 - Surgery after neoadjuvant therapy (CCB 2019)
17 Oct 2019 - 18:15-19:00 CET
Expert: Oreste Gentilini, San Raffaele Hospital, Milan, Italy
+  Go to this session

e-session 500 - Highlights of the 16th St Gallen International Breast Cancer Conference 2019
17 Oct 2019 - 18:15-19:00 CET
Expert: Fatima Cardoso, Champalimaud Clinical Center, Lisbon, Portugal
Discussant: Olivia Pagani, Riviera-Chablais Hospital, Rennaz, Switzerland
+  Go to this session

e-session 499 - MR guided radiotherapy: a new paradigm for cancer treatment
10 Oct 2019 - 18:15-19:00 CET
Expert: Daniel Zips, University Hospital and Medical Faculy, Tübingen, Germany
Discussant: Luca Boldrini, University Polyclinic Foundation “A. Gemelli” IRCCS, Rome, Italy
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 498001 - Perspectives on adolescent and young adult cancer as an emerging specialism and nursing’s role within it
08 Oct 2019 - 18:15-19:00 CET
Expert: Maria Cable, Coventry University, Coventry, United Kingdom
Discussant: Johan De Munter, University Hospital Ghent, Ghent, Belgium
+  Go to this session

e-session 498000 - Breast Unit of Southern Switzerland – Benefits of multidisciplinarity in early breast cancer treatment
07 Oct 2019 - 11:00-11:45 CET
Expert: Olivia Pagani, Riviera-Chablais Hospital, Rennaz, Switzerland
Expert: Antonella Richetti, Cantonal Hospital - EOC, Bellinzona, Switzerland
Expert: Francesco Meani, Regional Hospital of Lugano, Lugano, Switzerland
+  Go to this session

e-session 498 - EMR and ESD for colorectal lesions
03 Oct 2019 - 18:15-19:00 CET
Expert: Massimo Conio, Sanremo Hospital, Sanremo, Italy
Discussant: Michael Häfner, Private practice, Vienna, Austria
+  Go to this session

e-session 497 - Head & neck cancer patients: Integration of nutritional management in cancer care
26 Sep 2019 - 18:15-19:00 CET
Expert: Pierre Senesse, Regional Cancer Institute, Montpellier, France
Discussant: Alexander De Vries, Feldkirch Regional Hospital, Feldkirch, Austria
+  Go to this session

e-session 496000 - Treatment options in patients with metastatic gastric cancer
24 Sep 2019 - 16:00-16:45 CET
Expert: Sara De Dosso, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
Discussant: Andrés Cervantes, Hospital Clinico Universitario, Valencia, Spain
+  Go to this session

e-session 496 - IASLC's annual World Conference on Lung Cancer (WCLC) from the surgeon's point of view
19 Sep 2019 - 18:15-19:00 CET
Expert: Pietro Bertoglio, IRCCS Sacro Cuore-Don Calabria Hospital and Cancer Care Centre, Verona, Italy
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 495 - Nurses and doctors: a joint approach on a clinical case
12 Sep 2019 - 18:15-19:00 CET
Expert: Doris Posch, Barmherzige Schwestern Hospital, Vienna, Austria
Expert: Harald Titzer, Medical University Vienna, Vienna, Austria
+  Go to this session

e-session 494 - 1st line treatment in HL
05 Sep 2019 - 18:15-19:00 CET
Expert: Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina
Discussant: Eldad J. Dann, Rappaport Faculty of Medicine, Technion, Haifa, Israel
+  Go to this session

e-session 493001 - Nasopharynx carcinoma
03 Sep 2019 - 18:15-19:00 CET
Expert: Anthony Chan, The Chinese University of Hong Kong, Hong Kong SAR, China
Expert: Darren Poon, The Chinese University of Hong Kong, Hong Kong SAR, China
Discussant: Laura Locati, National Cancer Institute - IRCCS Foundation, Milan, Italy
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 493002 - Male breast cancer (CCB 2019)
28 Aug 2019 - 18:15-19:00 CET
Expert: Fatima Cardoso, Champalimaud Clinical Center, Lisbon, Portugal
+  Go to this session

e-session 493000 - Liquid biopsy in oncology
08 Aug 2019 - 18:15-19:00 CET
Expert: Federica Di Nicolantonio, University of Turin School of Medicine, Turin, Italy
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 493003 - Principles of standard diagnostics - Part 1: mammography and tomosynthesis (CCB 2019)
02 Aug 2019 - 18:15-19:00 CET
Expert: Francesca Caumo, Verona University - "G.B.Rossi" Polyclinic, Verona, Italy
+  Go to this session

e-session 493 - Highlights of ICML 2019
01 Aug 2019 - 18:15-19:00 CET
Expert: Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina
Discussant: Kerry Savage, BC Cancer, Vancouver, British Columbia, Canada
+  Go to this session

e-session 492000 - Radiotherapy after neoadjuvant therapy (CCB2019)
26 Jul 2019 - 18:15-19:00 CET
Expert: David Krug, Clinic for Radiation Therapy, Kiel, Germany
+  Go to this session

e-session 492 - ESTS annual meeting: the best of
25 Jul 2019 - 18:15-19:00 CET
Expert: Hasan Batırel, Marmara University Hospital, Istanbul, Turkey
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 491000 - Pharmacology of anticancer drugs (part I)
23 Jul 2019 - 16:00-16:45 CET
Expert: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Discussant: Markus Jörger, Cantonal Hospital, St.Gallen, Switzerland
+  Go to this session

e-session 491 - DNA repair defects in prostate cancer: which consequences/treatment modalities for daily practice?
18 Jul 2019 - 18:15-19:00 CET
Expert: Carmel Pezaro, Sheffield Teaching Hospital, Sheffield, United Kingdom
Discussant: Aurelius Omlin, Kantonsspital St. Gallen, St Gallen, Switzerland
+  Go to this session

e-session 490027 - Preoperative evaluation of patients with thyroid nodules (19BEM)
14 Jul 2019 - 18:15-19:00 CET
Expert: Gerasimos Sykiotis, Lausanne University Hospital, Lausanne, Switzerland
+  Go to this session

e-session 490028 - Update on management of differentiated thyroid cancer (19BEM)
14 Jul 2019 - 18:15-19:00 CET
Expert: Viktor Kondratovich, Minsk City Oncological Hospital, Minsk, Belarus
+  Go to this session

e-session 490029 - Multidisciplinary management of medullary and anaplastic thyroid cancers (19BEM)
14 Jul 2019 - 18:15-19:00 CET
Expert: Gerasimos Sykiotis, Lausanne University Hospital, Lausanne, Switzerland
+  Go to this session

e-session 490022 - Treatment of ovarian cancer (19BEM)
13 Jul 2019 - 18:15-19:00 CET
Expert: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 490023 - Surgery in gynaecological cancers (ovary, endometrial and cervical cancer) (19BEM)
13 Jul 2019 - 18:15-19:00 CET
Expert: Michael Halaska, Charles University, Prague, Czech Republic
+  Go to this session

e-session 490024 - ESGO guidelines in cervical cancer (19BEM)
13 Jul 2019 - 18:15-19:00 CET
Expert: Michael Halaska, Charles University, Prague, Czech Republic
+  Go to this session

e-session 490025 - Systemic treatment in cervical and endometrial cancer (metastatic cervical, adjuvant and metastatic endometrial) (19BEM)
13 Jul 2019 - 18:15-19:00 CET
Expert: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 490026 - Rare gyneacological cancers (19BEM)
13 Jul 2019 - 18:15-19:00 CET
Expert: Maria Del Grande, EOC - Ente Ospedaliero Cantonale, Bellinzona, Switzerland
+  Go to this session

e-session 490018 - Adjuvant and neo-adjuvant treatment of colon cancer (19BEM)
13 Jul 2019 - 18:15-19:00 CET
Expert: Demetris Papamichael, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
+  Go to this session

e-session 490020 - Management of rectal cancer (19BEM)
13 Jul 2019 - 18:15-19:00 CET
Expert: Demetris Papamichael, Bank of Cyprus Oncology Centre, Nicosia, Cyprus
+  Go to this session

e-session 490010 - Surgery of breast cancer (19BEM)
12 Jul 2019 - 18:15-19:00 CET
Expert: Anton Khorau, N.N. Alexandrov National Cancer Centre, Minsk, Belarus
+  Go to this session

e-session 490012 - Systemic treatment of luminal A and B breast cancer (19BEM)
12 Jul 2019 - 18:15-19:00 CET
Expert: Olivia Pagani, Riviera-Chablais Hospital, Rennaz, Switzerland
+  Go to this session

e-session 490013 - Systemic treatment of HER2+ breast cancer (19BEM)
12 Jul 2019 - 18:15-19:00 CET
Expert: Alvydas Cesas, Klaipeda University Hospital, Klaipeda, Lithuania
+  Go to this session

e-session 490014 - Systemic treatment of triple negative breast cancer (19BEM)
12 Jul 2019 - 18:15-19:00 CET
Expert: Evgeniya Kharchenko, N.N.Petrov Research Institute of Oncology, St. Petersburg, Russian Federation
+  Go to this session

e-session 490015 - Advanced Breast Cancer - ABC4 (19BEM)
12 Jul 2019 - 18:15-19:00 CET
Expert: Elzbieta Senkus, Medical University of Gdansk, Gdansk, Poland
+  Go to this session

e-session 490016 - Supportive care: prevention of nausea and vomiting, diarrhea, febrile neutropenia, skin toxicity as complication of TKI (19BEM)
12 Jul 2019 - 18:15-19:00 CET
Expert: Anton Snegovoy, N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation
+  Go to this session

e-session 490017 - Access to care: an old/new issue? Global and Eastern European issues (19BEM)
12 Jul 2019 - 18:15-19:00 CET
Expert: Alexandru Eniu, Interdisciplinary Cancer Service, HRC Hopital Riviera-Chablais, Rennaz, Switzerland
+  Go to this session

e-session 490 - Adjuvant therapy of soft tissue sarcomas
11 Jul 2019 - 18:15-19:00 CET
Expert: Paolo Casali, National Cancer Institute - IRCCS Foundation, Milan, Italy
Expert: Alessandro Gronchi, National Cancer Institute - IRCCS Foundation, Milan, Italy
Discussant: Jean-Yves Blay, Université Claude Bernard Lyon & Centre Léon Bérard, Lyon, France
+  Go to this session

e-session 490000 - Small cell lung cancer (19BEM)
11 Jul 2019 - 18:15-19:00 CET
Expert: Dragana Jovanovic, Pulmonology University Hospital,Clinical Center of Serbia, Belgrade, Serbia
+  Go to this session

e-session 490001 - Lung cancer radiotherapy (19BEM)
11 Jul 2019 - 18:15-19:00 CET
Expert: Paul Van Houtte, Institut Jules Bordet, Brussels, Belgium
+  Go to this session

e-session 490002 - Chemotherapy and targeted treatment if NSCLC (19BEM)
11 Jul 2019 - 18:15-19:00 CET
Expert: Sergei Tjulandin, N.N.Blokhin Russian Cancer Research Center, Moscow, Russian Federation
+  Go to this session

e-session 490003 - Principles of immunotherapy in lung cancer (19BEM)
11 Jul 2019 - 18:15-19:00 CET
Expert: Dragana Jovanovic, Pulmonology University Hospital,Clinical Center of Serbia, Belgrade, Serbia
+  Go to this session

e-session 490004 - Applying immunotherapy to NSCLC (19BEM)
11 Jul 2019 - 18:15-19:00 CET
Expert: Dragana Jovanovic, Pulmonology University Hospital,Clinical Center of Serbia, Belgrade, Serbia
+  Go to this session

e-session 490006 - Local therapy for prostate cancer (19BEM)
11 Jul 2019 - 18:15-19:00 CET
Expert: Paul Van Houtte, Institut Jules Bordet, Brussels, Belgium
+  Go to this session

e-session 490007 - First-line endocrine therapy in prostate cancer (19BEM)
11 Jul 2019 - 18:15-19:00 CET
Expert: Ali Shamseddine, American University of Beirut Medical Center, Beirut, Lebanon
+  Go to this session

e-session 490008 - Endocrine resistant/refractory prostate cancer (19BEM)
11 Jul 2019 - 18:15-19:00 CET
Expert: Sergey Polyakov, Republican Research and Practice Centre of Oncology and Medical Radiology n.a. N.N. Alexandrov, Minsk, Belarus
+  Go to this session

e-session 490009 - Advanced/metastatic renal cancer (19BEM)
11 Jul 2019 - 18:15-19:00 CET
Expert: Ilya Tsimafeyeu, Kidney Cancer Research Bureau - Russian Society of Clinical Oncology, Moscow, Russian Federation
+  Go to this session

e-session 489 - From guidelines to clinical practice: a roadmap to nutrition of cancer patients
04 Jul 2019 - 18:15-19:00 CET
Expert: Jann Arends, Freiburg University Hospital, Freiburg, Germany
Discussant: Maurizio Muscaritoli, University of Rome, Rome, Italy
+  Go to this session

e-session 488 - The role of particle therapy in modern oncology
27 Jun 2019 - 18:15-19:00 CET
Expert: Cai Grau, Aarhus University, Aarhus, Denmark
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
Discussant: Marco Schwarz, Proton Therapy Centre, Trento, Italy
+  Go to this session

e-session 487 - Strategies for delivering oncology care in low-resource settings
20 Jun 2019 - 18:15-19:00 CET
Expert: Temidayo Fadelu, Dana Farber Cancer Institute, Boston, USA
Discussant: Yehoda M. Martei, University of Pennsylvania, Philadelphia, PA, USA
+  Go to this session

e-session 486013 - FL chemo or chemo-free? (Lymphoma 2019)
17 Jun 2019 - 18:15-19:00 CET
Expert: Emanuele Zucca, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 486017 - High-Grade B-Cell NHL and BL (Lymphoma 2019)
17 Jun 2019 - 18:15-19:00 CET
Expert: Laurie Sehn, BC Cancer Agency, Vancouver Clinic, Vancouver, Canada
+  Go to this session

e-session 486014 - DLBCL Subtype-specific approaches? (Lymphoma 2019)
17 Jun 2019 - 18:15-19:00 CET
Expert: Andrew Davies, General Hospital, Southampton, UK
+  Go to this session

e-session 486015 - Hodgkin: Kairos vs chronos (escalate or de -escalate?) (Lymphoma 2019)
17 Jun 2019 - 18:15-19:00 CET
Expert: Peter W.M. Johnson, Cancer Research UK Centre, Southampton General Hospital, Southampton, United Kingdom
+  Go to this session

e-session 486016 - Novel approaches for the clinical trial design in hemato-oncology (Lymphoma 2019)
17 Jun 2019 - 18:15-19:00 CET
Expert: Anastasios Stathis, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
+  Go to this session

e-session 486018 - Mantle cell lymphoma (Lymphoma 2019)
17 Jun 2019 - 18:15-19:00 CET
Expert: Simon Rule, University Hospitals Plymouth, Plymouth, United Kingdom
+  Go to this session

e-session 486019 - Primary and secondary CNS involvement (Lymphoma 2019)
17 Jun 2019 - 18:15-19:00 CET
Expert: Tracy T. Batchelor, Massachusetts General Hospital, Boston, USA
+  Go to this session

e-session 486005 - Immune checkpoint inhibitors: Where do we stand (Lymphoma 2019)
16 Jun 2019 - 18:15-19:00 CET
Expert: Anas Younes, Memorial Sloan Kettering Cancer Center, New York, USA
+  Go to this session

e-session 486006 - CAR-T Cell Therapy: Where do we stand (Lymphoma 2019)
16 Jun 2019 - 18:15-19:00 CET
Expert: Sattva Neelapu, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
+  Go to this session

e-session 486007 - The AML Paradigm: From 3-7 to everybody to genetic-driven treatments (Lymphoma 2019)
16 Jun 2019 - 18:15-19:00 CET
Expert: Martin F. Fey, University Hospital, Inselspital, Berne, Switzerland
+  Go to this session

e-session 486009 - Main Indolent Entities: WM (Lymphoma 2019)
16 Jun 2019 - 18:15-19:00 CET
Expert: Giampaolo Merlini, IRCCS Fondation, Policlinico San Matteo, Pavia, Italy
+  Go to this session

e-session 486010 - Main Indolent Entities: CLL (Lymphoma 2019)
16 Jun 2019 - 18:15-19:00 CET
Expert: Davide Rossi, Oncology Institue of Southern Switzerland (IOSI), Bellinzona, Switzerland
+  Go to this session

e-session 486011 - Case discussion: Case 1 (Lymphoma 2019)
16 Jun 2019 - 18:15-19:00 CET
Expert: Bernhard Gerber, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
+  Go to this session

e-session 486020 - Case discussion: Case 2 (Lymphoma 2019)
16 Jun 2019 - 18:15-19:00 CET
Expert: Bernhard Gerber, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
+  Go to this session

e-session 486012 - Case discussion: Case 1 (Lymphoma 2019)
16 Jun 2019 - 18:15-19:00 CET
Expert: Alden Moccia, Oncology Institute of Southern Switzerland, Locarno, Switzerland
+  Go to this session

e-session 486021 - Case discussion: Case 2 (Lymphoma 2019)
16 Jun 2019 - 18:15-19:00 CET
Expert: Alden Moccia, Oncology Institute of Southern Switzerland, Locarno, Switzerland
+  Go to this session

e-session 486001 - Basics of B-NHL biology (Lymphoma 2019)
15 Jun 2019 - 18:15-19:00 CET
Expert: Ari M. Melnick, Weill Cornell Medical College, New York, USA
+  Go to this session

e-session 486002 - Basics of HL biology (Lymphoma 2019)
15 Jun 2019 - 18:15-19:00 CET
Expert: Ralf Küppers, University of Duisburg-Essen, Medical School, Essen, Germany
+  Go to this session

e-session 486003 - Basics of PTCLs biology (Lymphoma 2019)
15 Jun 2019 - 18:15-19:00 CET
Expert: Laurence de Leval, Lausanne University Hospital, Lausanne, Switzerland
+  Go to this session

e-session 486000 - A Prostate Cancer Unit, Hospital Clinico San Borja Arriarán: case discussion and solutions
14 Jun 2019 - 17:00-17:45 CET
Expert: Heinz Nicolai, Hospital Clinico San Borja, Arriarán, Chile
Discussant: Alejandro Mercado , Hospital Clinico San Borja, Arriarán, Chile
Discussant: Cesar Del Castillo, Hospital San Borja, Arriarán, Chile
Discussant: Fernando Vargas , Hospital Clinico San Borja, Arriarán, Chile
Discussant: Sebastian Solé, Hospital Clinico San Borja, Arriarán, Chile
+  Go to this session

e-session 486 - Artificial intelligence in oncology
13 Jun 2019 - 18:15-19:00 CET
Expert: Hugo Aerts, Dana-Farber Cancer Institute, Boston, MA, USA
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
Discussant: Jean Emmanuel Bibault, Stanford University, Stanford, CA, USA
+  Go to this session

e-session 485000 - A case on Diffuse Large B-Cell Lymphoma (DLBCL)
12 Jun 2019 - 18:15-19:00 CET
Expert: Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina
Discussant: Philippe Armand, Dana Farber Cancer Institute, Boston, MA, USA
Discussant: Laurie Sehn, BC Cancer Agency, Vancouver Clinic, Vancouver, Canada
+  Go to this session

e-session 485 - Digital pathology
06 Jun 2019 - 18:15-19:00 CET
Expert: Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Milan, Italy
Discussant: Roberto Salgado, GZA Hospitals, Antwerp, Belgium
+  Go to this session

e-session 484000 - VATS lobectomy in the treatment of locally advanced NSCLC
05 Jun 2019 - 18:15-19:00 CET
Expert: Thomas D'Amico, Duke University Medical Center, Durham, North Carolina, USA
Discussant: Luca Bertolaccini, European Institute of Oncology, Milan, Italy
+  Go to this session

e-session 484 - Highlights of ESTRO 38
30 May 2019 - 18:15-19:00 CET
Expert: Andrea Riccardo Filippi, Policlinico S. Matteo IRCCS Foundation, Pavia, Italy
Expert: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 483000 - Genetic counselling in colorectal cancer
28 May 2019 - 16:00-16:45 CET
Expert: Julian Barwell, University of Leicester, Leicester, United Kingdom
Discussant: Jivanji Vanita, University Hospitals of Leicester, Leicester, United Kingdom
+  Go to this session

e-session 483 - Radiomics as a tool for prediction in oncology
23 May 2019 - 18:15-19:00 CET
Expert: Philippe Lambin, Maastricht University, Maastricht, The Netherlands
Discussant: Nicola Dinapoli, University Polyclinic A. Gemelli IRCCS Foundation, Rome, Italy
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 482000 - Adjuvant treatment in colorectal cancer
21 May 2019 - 18:00-19:00 CET
Expert: Erika Ruiz, National Cancer Institute, Mexico City, Mexico
+  Go to this session

e-session 482001 - Multidisciplinary management of breast cancer: why is it crucial? (CCB 2019)
20 May 2019 - 18:15-19:00 CET
Expert: Fatima Cardoso, Champalimaud Clinical Center, Lisbon, Portugal
+  Go to this session

e-session 482 - Should patients with early breast cancer still be offered the choice of breast conserving surgery or mastectomy?
16 May 2019 - 18:15-19:00 CET
Expert: Oreste Gentilini, San Raffaele Hospital, Milan, Italy
Discussant: Thorsten Kühn, Klinikum Esslingen, Esslingen, Germany
+  Go to this session

e-session 481 - ESGO/ESMO Consensus Conference on Ovarian Cancer
09 May 2019 - 18:15-19:00 CET
Expert: Cristiana Sessa, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
Expert: Nicoletta Colombo, European Institute of Oncology, Milan, Italy
Discussant: Mikkel Rosendahl, Rigshospitalet, Copenhagen, Denmark
+  Go to this session

e-session 480 - Hypoxic cell sensitizers in head and neck cancer radiotherapy
02 May 2019 - 18:15-19:00 CET
Expert: Jesper Grau Eriksen, Odense University Hospital, Odense, Denmark
Discussant: Pierfrancesco Franco, University of Turin School of Medicine, Turin, Italy
+  Go to this session

e-session 479000 - Best of ISHL and ASH in HL
30 Apr 2019 - 16:00-16:45 CET
Expert: Astrid Pavlovsky, Clinical Research Center - FUNDALEU, Buenos Aires, Argentina
Discussant: Eva Domingo Domènech, Institut Català d'Oncologia, Hospitalet de Llobregat, Spain
+  Go to this session

e-session 477000 - Updates from ASCO GU 2019
27 Apr 2019 - 12:00-13:00 CET
Expert: Manuel Caitano Maia, Centro de Oncologia do Paraná, Curitiba - Paraná, Brazil
+  Go to this session

e-session 479 - Integration of oncology and palliative care
25 Apr 2019 - 18:15-19:00 CET
Expert: Stein Kaasa, Oslo University Hospital, Oslo, Norway
Expert: Karin Jordan, Heidelberg University Hospital, Heidelberg, Germany
Discussant: Jon Håvard Loge, Institute of Basic Medical Sciences, Oslo, Norway
+  Go to this session

e-session 478 - Immunotherapy related toxicities (held in collaboration with EONS)
18 Apr 2019 - 18:15-19:00 CET
Expert: Aileen O'Meara, St. Vincent's University Hospitals, Dublin, Ireland
Discussant: John Haanen, Netherland Cancer Institute Antoni Van Leeuwenhoek, Amsterdam, The Netherlands
+  Go to this session

e-session 478000 - First line treatment in ovarian cancer: one does not fit all
14 Apr 2019 - 12:00-13:00 CET
Expert: Ainhoa Madariaga, Princess Margaret Cancer Centre, Toronto, Canada
+  Go to this session

e-session 477 - Highlights of the 7th International Conference on Innovative Approaches in Head and Neck Oncology (ICHNO)
11 Apr 2019 - 18:15-19:00 CET
Expert: Paolo Bossi, University of Brescia, ASST Spedali Civili, Brescia, Italy
Discussant: Miren Taberna, Catalan Institute of Oncology (ICO), Barcelona, Spain
+  Go to this session

e-session 476 - Things about breast cancer that keep us up at night - Part I
04 Apr 2019 - 18:15-19:00 CET
Expert: Olivia Pagani, Riviera-Chablais Hospital, Rennaz, Switzerland
Discussant: Alexandru Eniu, Interdisciplinary Cancer Service, HRC Hopital Riviera-Chablais, Rennaz, Switzerland
+  Go to this session

//